[Treatment of peripheral arterial occlusive disorders with rheologically active measures].
Turowski
A
A
Klinik für Innere Medizin Theodor Brugsch, des Bereiches Medizin (Charité), Humboldt-Universität zu Berlin.
Schmidt
H H
HH
Sternitzky
R
R
D001157:Arterial Occlusive Diseases / Q000628:therapy*; D001772:Blood Cell Count; D001809:Blood Viscosity / Q000187:drug effects; D005080:Exercise Test; D005260:Female; D006400:Hematocrit; D006438:Hemodilution / Q000379:methods*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010431:Pentoxifylline / Q000008:administration & dosage*; D012212:Rheology; D013805:Theobromine / Q000031:analogs & derivatives*
D013805:Theobromine; D010431:Pentoxifylline
Die Behandlung peripherer arterieller Durchblutungsstörungen (PAD) mit rheologisch aktiven Massnahmen.